Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 1;100 Suppl 1(Suppl 1):S132-9.
doi: 10.2105/AJPH.2009.181628. Epub 2010 Feb 10.

Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials

Affiliations

Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials

Nancy Krieger et al. Am J Public Health. .

Erratum in

  • Am J Public Health. 2010 Jun;100(6):972

Abstract

Objectives: We investigated whether there were socioeconomic and racial/ethnic disparities in recent reported declines in overall US breast cancer incidence rates attributed to post-2002 declines in hormone therapy use following publication of the Women's Health Initiative study.

Methods: We analyzed 1992-2005 US breast cancer incidence data from the US Surveillance, Epidemiology and End Result (SEER) 13 Registries Database, stratified by race/ethnicity, county income level, age, and estrogen receptor (ER) status.

Results: As we hypothesized, between 1992 and 2005, the temporal pattern of rising and then falling US breast cancer incidence rates occurred only among White non-Hispanic women who lived in high-income counties, were aged 50 years and older, and had ER-positive tumors. No such trends were evident--regardless of county income level, ER status, or age--among Black non-Hispanic, Asian/Pacific Islander, Hispanic, or-where numbers were sufficient to conduct meaningful analyses-American Indian/Alaska Native women.

Conclusions: The recent decline in US breast cancer incidence was not equally beneficial to all women, but instead mirrored the social patterning of hormone therapy use. Joint information on socioeconomic resources and race/ethnicity is vital for correctly understanding disease distribution, including that of breast cancer.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Age-standardized breast cancer incidence rates (per 100 000; for all women and by race/ethnicity), stratified by county income level and age, for (a) all cases, (b) estrogen receptor (ER)-positive cases, (c) ER-negative cases, and (d) ER status unknown cases: US Surveillance, Epidemiology and End Result (SEER) 13 Registries Database, 1992–2005. Note. Rates are based on 3-year rolling averages, standardized to the year 2000 standard million.

References

    1. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton JL. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006;24(33):e49–e50 - PubMed
    1. Ravdin PM, Cronin KA, Howlader N, Chlebowski RT, Berry DA. A sharp decrease in breast cancer incidence in the United States in 2003. Presented at: 29th annual San Antonio Breast Cancer Symposium; December 14–17, 2006; San Antonio, TX: Available at: http://www.sabcs.org. Accessed February 8, 2007
    1. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356(16):1670–1674 - PubMed
    1. Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control. 2007;18(8):847–852 - PubMed
    1. Hausauer AK, Keegan THM, Chang ET, Clarke CA. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res. 2007;9(6):R90. - PMC - PubMed

Publication types

Substances